Become a leader in genomic medicine — applications open for PARADIGM fellowship until March 15
PARADIGM at UF invites applications for its postdoctoral fellowship program in genomic medicine.
All Posts by
PARADIGM at UF invites applications for its postdoctoral fellowship program in genomic medicine.
UF Health researchers have used a promising approach by integrating CRISPR/cas9-based drug screening with patients’ clinical outcome to identify genes and pathways that predict how patients will respond to the standard firstline chemotherapy treatment regimen used to treat patients with acute myeloid leukemia, or AML.
Al Saeed was one of two graduate students nationally to receive a 2024 ACCP Foundation Futures Grant.
Dr. Emily Cicali appeared on WCJB TV20 News in Gainesville to share information about the MyRx service.
Dr. Cicali was recognized during the STRIPE Annual Meeting & Consensus Workshop on Oct. 23 in Rockville, Maryland, celebrating her impactful work in pharmacogenomics.
Jürgen Bulitta, Ph.D., is among a team of UF researchers exploring how drug combinations can be tuned to defeat resistant bacteria.
Malavé received the Presidential Abstract Award at the Pharmacogenomics Global Research Network Scientific Meeting in Columbus, Ohio, on Sept. 24.
Jatinder Lamba, Ph.D., led a new study showing that a pharmacogenomics score developed at UF could be used by clinicians preemptively to match acute myeloid leukemia patients with the most effective treatment regimen to lead to remission.
Dr. Allen will officially begin his three-year term as treasurer in October 2025.
For the third consecutive year, the UF College of Pharmacy ranked No. 3 in all three major categories where annual research funding is reported by the AACP.